Arkolith/Insider Trading/SNSE

SNSE Insider Trading

SNSE · full profile →Last filing Jun 10, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

85 shown
DateInsiderRoleActionSharesPriceValue
Jun 10, 2026Donenberg Phillip B.DirectorGrant(A)13K—$0
Jun 10, 2026Holmen BobDirectorGrant(A)13K—$0
Jun 10, 2026Gerry ChristopherPresident & PEOGrant(A)220K—$0
Feb 13, 2026Donenberg Phillip B.DirectorGrant(A)2K—$0
Dec 9, 2025Peyer James10% OwnerSell(S)395$8.04$3K
Dec 9, 2025Peyer James10% OwnerSell(S)3K$7.95$21K
Dec 9, 2025Peyer James10% OwnerSell(S)446$7.92$4K
Dec 9, 2025Peyer James10% OwnerOption exercise(M)395$6.40$3K
Dec 9, 2025Peyer James10% OwnerOption exercise(M)395—$0
Dec 9, 2025Cambrian BioPharma Inc10% OwnerSell(S)3K$8.59$27K
Dec 9, 2025Cambrian BioPharma Inc10% OwnerSell(S)446$7.92$4K
Dec 9, 2025Cambrian BioPharma Inc10% OwnerSell(S)395$8.04$3K
Dec 9, 2025Cambrian BioPharma Inc10% OwnerSell(S)3K$7.95$21K
Dec 9, 2025Cambrian BioPharma Inc10% OwnerOption exercise(M)395$6.40$3K
Dec 9, 2025Cambrian BioPharma Inc10% OwnerOption exercise(M)395—$0
Dec 8, 2025Peyer James10% OwnerSell(S)3K$8.59$27K
Dec 5, 2025Peyer James10% OwnerSell(S)15K$11.40$165K
Dec 5, 2025Peyer James10% OwnerSell(S)42$13.16$553
Dec 5, 2025Peyer James10% OwnerSell(S)2K$12.29$21K
Dec 5, 2025Cambrian BioPharma Inc10% OwnerSell(S)15K$11.40$165K
Dec 5, 2025Cambrian BioPharma Inc10% OwnerSell(S)42$13.16$553
Dec 5, 2025Cambrian BioPharma Inc10% OwnerSell(S)2K$12.29$21K
Dec 4, 2025Peyer James10% OwnerSell(S)5K$9.06$45K
Dec 4, 2025Cambrian BioPharma Inc10% OwnerSell(S)5K$9.06$45K
May 21, 2025Ringo William RDirectorGrant(A)19K—$0
May 21, 2025Holmen BobDirectorGrant(A)19K—$0
May 21, 2025Humer KristianDirectorGrant(A)19K—$0
May 21, 2025Peyer JamesDirector, 10% OwnerGrant(A)19K—$0
May 21, 2025Ricks Thomas GDirectorGrant(A)19K—$0
May 21, 2025Cambrian BioPharma Inc10% OwnerGrant(A)19K—$0
Feb 19, 2025van der Horst EdwardCHIEF SCIENTIFIC OFFICERTax withholding(F)2K$0.48$1K
Feb 19, 2025Celebi JohnPRESIDENT AND CEO, DirectorTax withholding(F)6K$0.48$3K
Feb 14, 2025van der Horst EdwardCHIEF SCIENTIFIC OFFICERGrant(A)110K—$0
Feb 14, 2025Celebi JohnPRESIDENT AND CEO, DirectorGrant(A)360K—$0
Feb 14, 2025Craver JosiahPrincipal Financial OfficerGrant(A)50K—$0
Feb 14, 2025Krebs StephanieChief Business OfficerGrant(A)120K—$0
Dec 20, 2024Celebi JohnPRESIDENT AND CEO, DirectorGrant(A)355K—$0
Dec 20, 2024Craver JosiahPrincipal Financial OfficerGrant(A)100K—$0
Dec 20, 2024van der Horst EdwardCHIEF SCIENTIFIC OFFICERGrant(A)100K—$0
Dec 20, 2024Krebs StephanieChief Business OfficerGrant(A)120K—$0
Jun 11, 2024Vojta DeneenDirectorGrant(A)19K—$0
Jun 11, 2024Ricks Thomas GDirectorGrant(A)19K—$0
Jun 11, 2024Ringo William RDirectorGrant(A)19K—$0
Jun 11, 2024Humer KristianDirectorGrant(A)19K—$0
Jun 11, 2024English JessieDirectorGrant(A)19K—$0
Jun 11, 2024Holmen BobDirectorGrant(A)19K—$0
Jun 11, 2024Peyer JamesDirector, 10% OwnerGrant(A)19K—$0
Jun 11, 2024Cambrian BioPharma Inc10% OwnerGrant(A)19K—$0
Feb 15, 2024Colgan ErinCHIEF FINANCIAL OFFICERTax withholding(F)4K$0.79$3K
Feb 15, 2024Colgan ErinCHIEF FINANCIAL OFFICERGrant(A)125K—$0
Feb 15, 2024Colgan ErinCHIEF FINANCIAL OFFICERGrant(A)94K—$0
Feb 15, 2024Celebi JohnPRESIDENT AND CEO, DirectorTax withholding(F)6K$0.79$5K
Feb 15, 2024Celebi JohnPRESIDENT AND CEO, DirectorGrant(A)315K—$0
Feb 15, 2024Celebi JohnPRESIDENT AND CEO, DirectorGrant(A)166K—$0
Feb 15, 2024van der Horst EdwardCHIEF SCIENTIFIC OFFICERTax withholding(F)3K$0.79$2K
Feb 15, 2024van der Horst EdwardCHIEF SCIENTIFIC OFFICERGrant(A)125K—$0
Feb 15, 2024van der Horst EdwardCHIEF SCIENTIFIC OFFICERGrant(A)90K—$0
Nov 1, 2023Krebs StephanieChief Business OfficerGrant(A)125K—$0
Sep 11, 2023Celebi JohnPresident and CEO, DirectorBuy(P)500$0.85$425
Jul 31, 2023Cambrian BioPharma Inc10% OwnerDisposed to issuer(D)1.6M$1.26$2.0M
Jul 31, 2023Peyer JamesDirector, 10% OwnerDisposed to issuer(D)1.6M$1.26$2.0M
Jul 10, 2023Ringo William RDirectorGrant(A)15K—$0
Jul 10, 2023Ringo William RDirectorGrant(A)4K—$0
Jul 10, 2023Ricks Thomas GDirectorGrant(A)15K—$0
Jul 10, 2023Ricks Thomas GDirectorGrant(A)4K—$0
Jul 10, 2023Broder SamuelDirectorGrant(A)15K—$0
Jul 10, 2023Broder SamuelDirectorGrant(A)4K—$0
Jul 10, 2023Humer KristianDirectorGrant(A)15K—$0
Jul 10, 2023Humer KristianDirectorGrant(A)4K—$0
Jul 10, 2023English JessieDirectorGrant(A)15K—$0
Jul 10, 2023English JessieDirectorGrant(A)4K—$0
Jul 10, 2023Vojta DeneenDirectorGrant(A)15K—$0
Jul 10, 2023Vojta DeneenDirectorGrant(A)4K—$0
Jul 10, 2023Holmen BobDirectorGrant(A)15K—$0
Jul 10, 2023Holmen BobDirectorGrant(A)4K—$0
Jul 10, 2023Peyer JamesDirector, 10% OwnerGrant(A)15K—$0
Jul 10, 2023Peyer JamesDirector, 10% OwnerGrant(A)4K—$0
Jul 10, 2023Cambrian BioPharma Inc10% OwnerGrant(A)15K—$0
Jul 10, 2023Cambrian BioPharma Inc10% OwnerGrant(A)4K—$0
Jun 1, 2023Angermayer Christian10% OwnerSell(S)2.5M$1.58$3.9M
Jun 1, 2023Angermayer Christian10% OwnerSell(S)956K$1.58$1.5M
Feb 15, 2023Gallagher Patrick StephenChief Business OfficerTax withholding(F)9K$1.50$14K
Feb 15, 2023van der Horst EdwardChief Scientific OfficerTax withholding(F)10K$1.50$14K
Feb 15, 2023Celebi JohnPresident and CEO, DirectorTax withholding(F)20K$1.50$31K
Feb 15, 2023Colgan ErinChief Financial OfficerTax withholding(F)11K$1.50$16K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).